A detailed history of First National Bank & Trust CO Of Newtown transactions in Abb Vie Inc. stock. As of the latest transaction made, First National Bank & Trust CO Of Newtown holds 13,772 shares of ABBV stock, worth $2.8 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
13,772
Previous 13,772 -0.0%
Holding current value
$2.8 Million
Previous $2.36 Million 15.11%
% of portfolio
0.52%
Previous 0.48%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$154.79 - $180.76 $145,966 - $170,456
-943 Reduced 6.41%
13,772 $2.36 Million
Q1 2024

Apr 29, 2024

SELL
$159.82 - $182.1 $22,374 - $25,494
-140 Reduced 0.94%
14,715 $2.68 Million
Q4 2023

Jan 31, 2024

SELL
$137.6 - $154.97 $34,400 - $38,742
-250 Reduced 1.66%
14,855 $2.3 Million
Q3 2023

Nov 01, 2023

SELL
$133.59 - $154.65 $73,474 - $85,057
-550 Reduced 3.51%
15,105 $2.25 Million
Q2 2023

Jul 31, 2023

SELL
$132.51 - $164.9 $28,489 - $35,453
-215 Reduced 1.35%
15,655 $2.11 Million
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $36,152 - $41,635
-250 Reduced 1.55%
15,870 $2.53 Million
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $6,192 - $7,873
-45 Reduced 0.28%
16,120 $2.47 Million
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $46,193 - $57,312
-350 Reduced 2.12%
16,165 $2.62 Million
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $21,486 - $27,186
200 Added 1.23%
16,515 $2.24 Million
Q3 2021

Oct 20, 2021

BUY
$106.4 - $120.78 $5,320 - $6,039
50 Added 0.31%
16,315 $1.76 Million
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $1,052 - $1,172
10 Added 0.06%
16,265 $1.83 Million
Q1 2021

May 06, 2021

SELL
$102.3 - $112.62 $192,426 - $211,838
-1,881 Reduced 10.37%
16,255 $1.76 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $39,842 - $53,791
495 Added 2.81%
18,136 $1.94 Million
Q3 2020

Nov 06, 2020

BUY
$85.91 - $100.83 $90,635 - $106,375
1,055 Added 6.36%
17,641 $1.55 Million
Q2 2020

Aug 04, 2020

BUY
$73.37 - $98.18 $34,263 - $45,850
467 Added 2.9%
16,586 $1.63 Million
Q4 2019

Jan 30, 2020

SELL
$72.13 - $90.25 $14,426 - $18,050
-200 Reduced 1.23%
16,119 $1.43 Million
Q2 2019

Jul 17, 2019

SELL
$65.7 - $83.98 $19,710 - $25,194
-300 Reduced 1.81%
16,319 $1.19 Million
Q4 2018

Jan 18, 2019

SELL
$77.85 - $96.01 $54,494 - $67,207
-700 Reduced 4.04%
16,619 $1.53 Million
Q3 2018

Oct 30, 2018

SELL
$88.91 - $98.84 $32,452 - $36,076
-365 Reduced 2.06%
17,319 $1.64 Million
Q2 2018

Jul 31, 2018

SELL
$89.78 - $106.23 $4,489 - $5,311
-50 Reduced 0.28%
17,684 $1.64 Million
Q1 2018

Apr 27, 2018

BUY
$92.01 - $123.21 $57,506 - $77,006
625 Added 3.65%
17,734 $1.68 Million
Q4 2017

Jan 17, 2018

SELL
$89.56 - $98.21 $62,692 - $68,747
-700 Reduced 3.93%
17,109 $1.66 Million
Q3 2017

Oct 25, 2017

BUY
$69.85 - $89.22 $1.24 Million - $1.59 Million
17,809
17,809 $1.58 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First National Bank & Trust CO Of Newtown Portfolio

Follow First National Bank & Trust CO Of Newtown and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank & Trust CO Of Newtown, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank & Trust CO Of Newtown with notifications on news.